Daniel Virgil Thomas Catenacci
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 10
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 3
-
- Gastric Cancer Management and Outcomes 5
- Advanced Breast Cancer Therapies 3
- Co-authors
- Emily Chan (3 shared papers)Tanios Bekaii‐Saab (3 shared papers)Shilpa Gupta (3 shared papers)Veena Shankaran (3 shared papers)Raanan Berger (3 shared papers)Kei Muro (3 shared papers)Ravit Geva (3 shared papers)Jonathan D. Cheng (3 shared papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Daniel Virgil Thomas Catenacci
19 papers receiving 524 citations
Peers
Comparison fields: 5 of 31
- Oncology 324
- Gastroenterology 61
- Pulmonary and Respiratory Medicine 225
- Hepatology 53
- Pathology and Forensic Medicine 89
Countries citing papers authored by Daniel Virgil Thomas Catenacci
This map shows the geographic impact of Daniel Virgil Thomas Catenacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Virgil Thomas Catenacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Virgil Thomas Catenacci more than expected).
Fields of papers citing papers by Daniel Virgil Thomas Catenacci
This network shows the impact of papers produced by Daniel Virgil Thomas Catenacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Virgil Thomas Catenacci. The network helps show where Daniel Virgil Thomas Catenacci may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Virgil Thomas Catenacci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 123 | |
| 2 | 2015 | 95 | |
| 3 | 2015 | 94 | |
| 4 | 2015 | 37 | |
| 5 | 2013 | 33 | |
| 6 | 2013 | 31 | |
| 7 | 2015 | 31 | |
| 8 | 2015 | 22 | |
| 9 | 2012 | 18 | |
| 10 | 2013 | 16 | |
| 11 | 2015 | 16 | |
| 12 | 2014 | 8 | |
| 13 | 2015 | 6 | |
| 14 | 2015 | 3 | |
| 15 | 2012 | 2 | |
| 16 | 2015 | 2 | |
| 17 | 2014 | 2 | |
| 18 | 2014 | 1 | |
| 19 | 2014 | 1 |
About Daniel Virgil Thomas Catenacci
Daniel Virgil Thomas Catenacci is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 19 papers that have together received 541 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Gastric Cancer Management and Outcomes (5 papers), Hedgehog Signaling Pathway Studies (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Oncology (324 citations), Gastroenterology (61 citations), Pulmonary and Respiratory Medicine (225 citations), Hepatology (53 citations) and Pathology and Forensic Medicine (89 citations). Daniel Virgil Thomas Catenacci has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Emily Chan, Tanios Bekaii‐Saab, Shilpa Gupta, Veena Shankaran, Raanan Berger, Kei Muro, Ravit Geva, Jonathan D. Cheng, Minori Koshiji and Joseph P. Eder. Their work appears in journals such as Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.